Disruption of EphA/ephrin-A signaling in the nigrostriatal system reduces dopaminergic innervation and dissociates behavioral responses to amphetamine and cocaine

Molecular and Cellular Neuroscience

Volumn 26, Issue 3, 2004, Pages 418-428

  Sieber, Beth Anne ^a   Kuzmin, Alexander ^a   Canals, Josep M ^b   Danielsson, Anne ^a   Paratcha, Gustavo ^a   Arenas, Ernest ^a   Alberch, Jordi ^b   Ögren, Sven Ove ^a   Ibáñez, Carlos F ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; COCAINE; DOPAMINE; EPHRIN A5; EPHRIN RECEPTOR A5; FLUOROGOLD; RECEPTOR BLOCKING AGENT;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN SIZE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CORPUS STRIATUM; DISSOCIATION; DOPAMINERGIC NERVE CELL; DOPAMINERGIC SYSTEM; DOPAMINERGIC TRANSMISSION; LOCOMOTION; MOUSE; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SUBSTANTIA NIGRA; TRANSGENIC MOUSE; WILD TYPE;

AMPHETAMINE; ANIMALS; COCAINE; CORPUS STRIATUM; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MICE; MICE, TRANSGENIC; MOTOR ACTIVITY; RATS; RECEPTORS, EPH FAMILY; SIGNAL TRANSDUCTION; SUBSTANTIA NIGRA;

MUS MUSCULUS;

EID: 3242812794     PISSN: 10447431     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcn.2004.03.009     Document Type: Article

References (39)

1. Abercrombie M. Estimation of nuclear populations from microtome sections. Anat. Rec. 94:1946;239-247
2. Brenner M., Messing A. GFAP transgenic mice. Methods. 10:1996;351-364
3. Brenner M., Kisseberth W.C., Su Y., Besnard F., Messing A. GFAP promoter directs astrocyte-specific expression in transgenic mice. J. Neurosci. 14:1994;1030-1037
4. Canals J., Checa N., Marco S., Åkerud P., Michels A., Pérez-Navarro E., Tolosa E., Arenas E., Alberch J. Expression of brain-derived neurotrophic factor in cortical neurons is regulated by striatal damage. J. Neurosci. 21:2001;117-124
5. Cheng H.J., Nakamoto M., Bergemann A.D., Flanagan J.G. Complementary gradients in expression and binding of ELF-1 and mek4 in development of the topographic retinotectal projection map. Cell. 82:1995;371-381
6. Dalva M.B., Takasu M.A., Lin M.Z., Shamah S.M., Hu L., Gale N.W., Greenberg M.E. EphB receptors interact with NMDA receptors and regulate excitatory synapse formation. Cell. 103:2000;945-956
7. Davy A., Gale N.W., Murray E.W., Klinghoffer R.A., Soriano P., Feuerstein C., Robbins S.M. Compartmentalized signaling by GPI-anchored ephrin-A5 requires the Fyn tyrosine kinase to regulate cellular adhesion. Genes Dev. 13:1999;3125-3135
8. Dodelet V.C., Pasquale E.B. Eph receptors and ephrin ligands: embryogenesis to tumorigenesis. Oncogene. 19:2000;5614-5619
9. Drescher U., Kremoser C., Handwerker C., Loschinger J., Noda M., Bonhoeffer F. In vitro guidance of retinal ganglion cell axons by RAGS, a 25 kDa tectal protein related to ligands for eph receptor tyrosine kinases. Cell. 82:1995;359-370
10. Flanagan J.G., Vanderhaeghen P. The ephrins and eph receptors in neural development. Annu. Rev. Neurosci. 21:1998;309-345
11. Frisen J., Holmberg J., Barbacid M. Ephrins and their Eph receptors: multitalented directors of embryonic development. EMBO J. 18:1999;5159-5165
12. Gale N.W., Holland S.J., Valenzuela D.M., Flenniken A., Pan L., Ryan T.E., Henkemeyer M., Strebhardt K., Hirai H., Wilkinson D.G., et al. Eph receptors and ligands comprise two major specificity subclasses and are reciprocally compartmentalized during embryogenesis. Neuron. 17:1996;9-19
13. Gao P.P., Zhang J.H., Yokoyama M., Racey B., Dreyfus C.F., Black I.B., Zhou R. Regulation of topographic projection in the brain-elf-1 in the hippocamposeptal system. Proc. Natl. Acad. Sci. U. S. A. 93:1996;11161-11166
14. Gao W.Q., Shinsky N., Armanini M.P., Moran P., Zheng J.L., Mendozaramirez J.L., Phillips H.S., Winslow J.W., Caras I.W. Regulation of hippocampal synaptic plasticity by the tyrosine kinase receptor, rek7/epha5, and its ligand, al-1/ephrin-a5. Mol. Cell. Neurosci. 11:1998;247-259
15. Heikkila R.E., Orlansky H., Cohen G. Studies on the distinction between uptake inhibition and release of (3H)dopamine in rat brain tissue slices. Biochem. Pharmacol. 24:1975;847-852
16. Holder N., Klein R. Eph receptors and ephrins: effectors of morphogenesis. Development. 126:1999;2033-2044
17. Holland S.J., Gale N.W., Mbamalu G., Yancopoulos G.D., Henkemeyer M., Pawson T. Bidirectional signalling through the eph-family receptor nuk and its transmembrane ligands. Nature. 383:1996;722-725
18. Holmberg J., Frisen J. Ephrins are not only unattractive. Trends Neurosci. 25:2002;239-243
19. Holmberg J., Clarke D.L., Frisen J. Regulation of repulsion versus adhesion by different splice forms of an Eph receptor. Nature. 408:2000;203-206
20. Jones S.R., Gainetdinov R.R., Wightman R.M., Caron M.G. Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter. J. Neurosci. 18:1998;1979-1986
21. Kelly M.A., Rubinstein M., Phillips T.J., Lessov C.N., Burkhart-Kasch S., Zhang G., Bunzow J.R., Fang Y., Gerhardt G.A., Grandy D.K., Low M.J. Locomotor activity in D2 dopamine receptor-deficient mice is determined by gene dosage, genetic background, and developmental adaptations. J. Neurosci. 18:1998;3470-3479
22. Klein R. Bidirectional signals establish boundaries. Curr. Biol. 9:1999;R691-R694
23. Knoll B., Drescher U. Ephrin-As as receptors in topographic projections. Trends Neurosci. 25:2002;145-149
24. Krull C.E., Lansford R., Gale N.W., Collazo A., Marcelle C., Yancopoulos G.D., Fraser S.E., Bronnerfraser M. Interactions of eph-related receptors and ligands confer rostrocaudal pattern to trunk neural crest migration. Curr. Biol. 7:1997;571-580
25. Lackmann M., Oates A.C., Dottori M., Smith F.M., Do C., Power M., Kravets L., Boyd A.W. Distinct subdomains of the EphA3 receptor mediate ligand binding and receptor dimerization. J. Biol. Chem. 273:1998;20228-20237
26. Larsson L.G., Renyi L., Ross S.B., Svensson B., Angeby-Moller K. Different effects on the responses of functional pre- and postsynaptic 5-HT1A receptors by repeated treatment of rats with the 5-HT1A receptor agonist 8-OH-DPAT. Neuropharmacology. 29:1990;86-91
27. Lemke G. Eph receptors and ligands in axon pathway choice, target recognition, and synaptogenesis. Prog. Brain Res. 117:1998;171-176
28. Magnusson O., Nilsson L.B., Westerlund D. Simultaneous determination of dopamine, DOPAC and homovanillic acid. Direct injection of supernatants from brain tissue homogenates in a liquid chromatography-electrochemical detection system. J. Chromatogr. 221:1980;237-247
29. Maisonpierre P.C., Barrezueta N.X., Yancopoulos G.D. Ehk-1 and Ehk-2: two novel members of the Eph receptor-like tyrosine kinase family with distinctive structures and neuronal expression. Oncogene. 8:1993;3277-3288
30. Ögren S.O., Ross S.B. Substituted amphetamine derivatives: II. Behavioural effects in mice related to monoaminergic neurones. Acta Pharm. Toxicol. (Copenh.). 41:1977;353-368
31. Ögren S.O., Hall H., Köhler C., Magnusson O., Sjöstrand S.E. The selective dopamine D2 receptor antagonist raclopride discriminates between dopamine-mediated motor functions. Psychopharmacology (Berl.). 90:1986;287-294
32. O'Leary D.D., Wilkinson D.G. Eph receptors and ephrins in neural development. Curr. Opin. Neurobiol. 9:1999;65-73
33. O'Malley E.K., Sieber B.A., Morrison R.S., Black I.B., Dreyfus C.F. Nigral type I astrocytes release a soluble factor that increases dopaminergic neuron survival through mechanisms distinct from basic fibroblast growth factor. Brain Res. 647:1994;83-90
34. Sabol K.E., Seiden L.S. Reserpine attenuates D-amphetamine and MDMA-induced transmitter release in vivo: a consideration of dose, core temperature and dopamine synthesis. Brain Res. 806:1998;69-78
35. Takasu M.A., Dalva M.B., Zigmond R.E., Greenberg M.E. Modulation of NMDA receptor-dependent calcium influx and gene expression through EphB receptors. Science. 295:2002;491-495
36. Ungerstedt U. Postsynaptic supersensitivity after 6-hydroxy-dopamine induced degeneration of the nigro-striatal dopamine system. Acta Physiol. Scand., Suppl. 367:1971;69-93
37. Wilkinson D.G. Multiple roles of EPH receptors and ephrins in neural development. Nat. Rev., Neurosci. 2:2001;155-164
38. Yue Y., Widmer D.A., Halladay A.K., Cerretti D.P., Wagner G.C., Dreyer J.L., Zhou R. Specification of distinct dopaminergic neural pathways: roles of the Eph family receptor EphB1 and ligand ephrin-B2. J. Neurosci. 19:1999;2090-2101
39. Zhang J.H., Cerretti D.P., Yu T., Flanagan J.G., Zhou R.P. Detection of ligands in regions anatomically connected to neurons expressing the eph receptor bsk-potential roles in neuron-target interaction. J. Neurosci. 16:1996;7182-7192